<DOC>
	<DOCNO>NCT03092752</DOCNO>
	<brief_summary>Appropriate use oral antidiabetic drug ( OADs ) include dose-reduction important patient 's safety T2DM patient renal impairment ( RI ) . However , insufficient data dose adjustment accordance prescription pattern risk RI OADs , particular DPP-4 inhibitor , clinical practice Japan . Therefore , investigate OADs usage condition dose selection T2DM patient RI clinical practice Japan</brief_summary>
	<brief_title>Clinical Characteristics Practice Patterns T2DM Patients Treated With OADs Japan : Analysis Medical Health Care Database MDV</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion : Patients T2DM ( ICD code : E11 E14 ) . Patients must first prescription ( defined index date* ) study drug 01/01/2014 30/09/2016 . Patients must least 6 month enrolment verify presence record except study drug prescription within database ( look back period ) prior index date drug . Exclusion criterion : Patients 40 year time diagnosis diabetes . Patients record type 1 diabetes mellitus . Patients prescribe study drug 6 month prior index date drug . Patients whose mean visit interval 92 day</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>